Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06290154
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2024-02-26
Brief Title:
Factors Associated With Posttransplant Cardiac Outcomes
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Study Overview
Official Title:
Factors Associated With Short-Term Major Adverse Cardiovascular Events After Liver Transplantation
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cardiovascular disease has become the leading cause of death early after liver transplantation LT The aging LT population is accompanied with the increasing prevalence of cardiovascular risk factors such as hypertension diabetes and hyperlipidemia Furthermore cirrhosis has been known to cause alterations in the systemic haemodynamic system and cardiac muscle dysfunction systolic andor diastolic known as Cirrhotic cardiomyopathy CCM Hence transthoracic echocardiography is required in all LT candidates for preprocedural evaluation and risk stratification However traditional echocardiographic indices of cardiac function have low sensitivity It is unclear whether comprehensive echocardiographic multiparameters including speckle tracking echocardiograph STE and tissue doppler imaging TDI can help improve preoperative risk stratification Therefore we sought to analyze the ability of clinical and comprehensive echocardiography variables to predict intraoperative and perioperative cardiac events and cardiac mortality in our LT patient experience up to early post-liver transplant
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None